Expression of Estrogen Receptors in Placentas Originating from Premature Deliveries Induced by Arterial Hypertension by Andrzej Plewka et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
9 
Expression of Estrogen Receptors in Placentas 
Originating from Premature Deliveries  
Induced by Arterial Hypertension 
Andrzej Plewka1, Danuta Plewka2 and Grażyna Nowaczyk3 
1Department of Proteomics, Medical University of Silesia in Sosnowiec 
2Department of Histology, Medical University of Silesia in Katowice 
3 Department of Physiology, School of Health Care, Medical University of Silesia, 
Katowice, 
Poland 
1. Introduction 
The role of sex steroids and their activity involve complex intracellular reactions and 
depend upon presence of a specific steroid receptor. Estrogens influence several processes in 
the human body, including tissues distant from genital organs. In the estrogen-dependent 
tissues the hormones control cell proliferation and influence cell differentiation. 
Studies indicate that estrogens and estrogen receptors play important physiological roles in 
cardiovascular disease [1]. 
Estrogens act by controlling expression of specific genes in target cells [2,3]. Their 
transcriptional activity is mediated by two estrogen receptors, ER-and ER-, similar in 
structure and function.  
Till the end of 1980s transmission of the message carried by the hormone was thought to be 
mediated by a single estrogen receptor only. In the mid 1990s studies were published which 
described the discovery of a new estrogen receptor in both animals and humans [4-7].  
The new estrogen receptor, ER-proved to be highly homologous to the classical estrogen 
receptor, ER-  
Functional differences at the molecular level between ER- and ER- are of principal 
importance for the body. Just as importantly, in the case of estrogen receptors the same 
ligand may play role of either an agonist or antagonist, depending on whether it binds to 
ER- or ER-. Therefore, following binding of the ligand ER- and ER- may induce distinct 
biological effects, linked to conformational changes of the receptor [8]. 
The transmission of estrogen-carried signal plays a significant role not only in normal but 
also in neoplastically altered tissues. The mediator in transmission of estrogen-carried 
message involves estrogen receptors, acting as transcription factors, activated by ligands [8-
11] and by alternative pathways of growth factor intracellular signalling [12,13]. Their 
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activity is subjected to intracellular control and is regulated by several tissue-dependent co-
modulators. Tissue distribution of the latter determines the final effect, i.e., activation or 
repression of the estrogen-dependent genes. Co-modulators are significant for activity of 
estrogen receptors and represent the functional link between the receptor and 
transcriptional apparatus [14,15].  
Gestosis represents a disease developing with an elevated arterial blood pressure. It may be 
accompanied by proteinuria and/or oedemas. The disease poses a high risk both to the 
mother and the fetus. There are several subtypes of the disease and it seems that the 
pregnancy-induced hypertension is of a key significance. Gestosis develops in as many as 8-
10% pregnancies after their 20th week [16-20].  
Pregnancy is associated with vascular adaptations. These adaptations are critical in 
pregnancy because their dysfunctions are implicated in pathological pregnancies, such as 
preeclampsia and other disorders [21-23]. The vascular adaptations are mediated by 
estrogens. 
Development of a normally functioning placenta requires an extreme coordination between 
various cellular structures, depending on specific growth factors and highly related to 
reciprocal signalling between the cells. 
We evaluated the two estrogen receptors, which participate in control of several functions 
[8,24,25]. We hoped that the investigations might prove helpful in evaluation of pathology 
developing in placentas obtained from mothers with pre-term delivery. In order to achieve 
the goal we evaluated differences in expression of selected receptors in placentas originating 
from normal pregnancies as compared to those from pre-term deliveries, burdened in 
addition by arterial hypertension in the mother. 
Thus, the principal aim of the studies involved characterization of changes in ER- and ER- 
expression in placentas obtained from healthy women and from women who demonstrated 
pregnancy-induced hypertension and who developed pre-term delivery. It was also planned 
to examine changes in quantitative distribution of the two receptors in central portions of 
the placentas as compared to their peripheral fragments. 
2. Material and methods 
2.1 Material 
The control group included placentas obtained from 20 women, aging 21 to 34 years, 
originating from deliveries at term, in 37th week of pregnancy, with a normal blood 
pressure during the entire pregnancy. 
The experimental group I included placentas from 20 patients aging 22 to 34 years, 
originating from pre-term deliveries between 26th and 32nd week of pregnancy, induced by 
hypertension, which developed between 20th and 25th week of pregnancy. 
The experimental group II consisted of placentas obtained from 20 mothers, aging 24 to 34 
years, following pre-term deliveries between 33rd and 37th week of pregnancy, induced by 
hypertension, which developed between 20th and 25th week of pregnancy. 
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The placentas were macroscopically examined, their weight, width and thickness were 
recorded and then, their samples were taken, comprising full cross-section of placenta with 
all its components, including amnion epithelium and basal decidua. 
Before isolation of placenta samples the patients were informed on the aim of the studies. 
The planned investigative procedures were approved by the Medical Bioethical 
Commission. 
2.2 Sampling of the material 
Placenta samples, 0.5-1.0 cm in width, were isolated from the central zone, around the 
umbilical cord, and from the peripheral zone. 
Samples targeted for immunohistochemical and morphological investigations were 
immersed in a buffered solution of paraformaldehyde. The tissue samples were fixed in 4% 
(w/v) paraformaldehyde solution buffered with phosphates of physiological saline (PBS) 
for 24 hours, at the temperature of 40 C, and dehydrated in a row of alcohols of increasing 
concentration (50%, 70%, 95% and 100% - 3 times of 20 min each), clear in xylene (3x10 min), 
and left in 1:1 mixture of xylene and paraffin at room temperature overnight. Subsequently, 
the samples were transferred to paraffin of the temperature not higher than 600 C for three 
hours, exchanging paraffin every full hour, and were embedded in paraffin blocks.  
The paraffin blocks were sectioned at 5 m using a rotary microtome and the sections were 
placed on silanized microscope glasses. Before immunohistochemical tests the preparations 
were deparaffinized in an incubator (15 min, 560 C), and xylene (3 x 10 min) and rehydrated 
in a row of alcohols of a decreasing concentration, starting at the absolute alcohol and 
terminating at 30% alcohol, three minutes at every stem. Finally, the preparations were 
washed in distilled water and, then, in 10 mM PBS, pH 7.5.  
In order to unmask antigens the preparations were boiled in a microwave oven (750 W) for 
20 minutes in 10 mM citrate buffer, pH 6.0.  
After cooling, they were washed in a buffer and activity of endogenous peroxidase was 
blocked by incubation with 1.5% (v/v) H2O2 in methanol for 10 minutes. Sites of non-
specific binding were blocked using non-immunised, normal animal serum obtained from 
the animal in which later on secondary antibody was obtained, for 30 min at room 
temperature.  
2.3 Antibodies 
Monoclonal mouse anti-ER-, directed against human estrogen receptor , were purchased 
from Zymed Laboratories Inc., and used at the concentration of 1 g/ml. Polyclonal rabbit 
anti-ER-, directed to human estrogen receptor , were obtained from Affinity Bioreagents 
Inc., and used at the concentration of 5 g/ml. 
2.4 Immunohistochemistry 
After removal of serum, sections were overlaid with an appropriate primary antibody and 
left overnight at the temperature of 40 C. Sites of primary antibody binding were visualized 
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using ABC technique. The sections were overlaid with appropriate secondary antibodies 
and, then, with avidin-biotinylated peroxidase complex (Vectastain ABC Kit, Vector 
Laboratories). The ABC complex was made visible using peroxidase substrate containing 3,3 
diaminobenzidine (DAB) and hydrogen peroxide, in accordance with manufacturer’s 
protocol (Vector Laboratories). The preparations were counterstained with Gill’s 
hematoxylin, dehydrated and mounted. The negative control consisted of sections in which 
primary antibody was substituted by non-immunized serum of the animal in which 
subsequently primary antibody was obtained. In order to eliminate non-specific reactions 
the negative control was run in parallel on every slide. 
An intra-organ and intra-cellular localization was evaluated under a light microscope 
(Nikon) at the magnification of 200x.  
A quantitative analysis was conducted of ER- and ER-estrogen receptor contents. 
Using the KS100 computer software, optical density of microscope preparations was 
estimated in sites in which the colour immunohistochemical reaction developed. 
Absorption of the light wavelength pointed to optical density of cells in the cytoplasm, 
nucleus of which complexes of antibody with ER- or ER-were detected, reflecting the 
content of the reaction product. 
The image analysis software of KS SA series was produced by Carl Zeiss Vision, Germany. 
The KS100/IBAS-C software was designed for measurements of interactively indicated 
geometric and densitometric parameters. At the stage of quantitative analysis 
autocalibration of the IBAS-C system takes place permitting calculations of surface area, 
mean lucidity, mean integrated lucidity, saturation coefficient, saturation coefficient in the 
scale of 1 to 255 and in % scale. 
2.5 Statistical analysis  
The results were collected in an Excel spread sheet (Microsoft, USA), and subsequently it 
was exported to STATISTICA software (Stat Soft, USA) to conduct statistical calculations. 
For results of densitometric studies, estimation of significance of differences between 
placenta centre and periphery Student’s t test for linked variables was used. On the other 
hand, Student’s t test for unlinked variables was employed for inter-group differences. The 
differences were regarded significant at p ≤ 0.05 level. 
3. Results 
3.1 Estrogen receptor ER- 
In the studies the placentas which were obtained from pre-term deliveries, were used in two 
groups: placentas from deliveries between 26th and 32nd week and those from deliveries 
between 33rd and 37th week. The control group consisted of placentas from at term 
deliveries.  
Optical density of cells with expression of estrogen receptor reflects concentration of 
immunocytochemical reaction product in examined cells. Two types of the receptor, i.e., ER-
 and ER-were evaluated. 
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Appraisal of ER- level in cytotrophoblast cells demonstrated a clearly decreasing optical 
density level of the product beginning at placentas from deliveries in the 26th-32nd week 
and ending at placentas from at term deliveries (Figures 1 and 2). The same analysis of 
peripheral parts of placentas showed that ER- level was similar in the two experimental 
groups and in at term placentas (Figure 3).  
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Fig. 1. Optical density of estrogen receptor ER- in some cells originating from central part 
of human placentas originating from various periods of delivery. The data represent mean 
values ± SD. * - statistically significant (p<0.05) in comparison with normal group 
No significant differences were detected between placenta centre and placenta periphery in 
cytotrophoblast cell optical density tested for expression of estrogen receptor ER- 
Analysis of ER- distribution in decidua cells documented an abrupt, almost 100% decrease 
in concentration of the receptor between the group of placentas from 26th-32nd week and 
the group from 33rd-37th week in the central portion of placenta (Figures 1 and 2). Even 
lower expression of the receptor was detected the control group, in which ER- level was 
three fold lower than in the experimental group I. Peripheral portions of the placentas 
manifested no more pronounced differences in ER- concentrations in decidua cells 
between the studied groups (Figure 3).  
Comparisons of product content in decidua cells following reaction for estrogen receptor ER- 
manifested significant differences between central and peripheral part of placentas from pre-
term deliveries (33rd and 37th week) and placentas originating from at term deliveries. 
In the central portion of placentas originating from pre-term deliveries in 26th-32nd week 
optical density of endothelial cells with expression of estrogen receptor ER- reached the 
highest value. In the subsequent group of placentas, originating from deliveries between 
33rd and 37th week, the documented value amounted to around 70% of the level typical for 
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Fig. 2. Expression of estrogen receptor ER- in decidual cells indicated by arrow (A,B), 
syncytiotrophoblasts (arrow) and endothelial cells (asterix) (C), cytotrophoblast cells 
(arrows) (E), Hofbauer’s cells (arrow) (F), and no expression in amnion epithelium (arrow) 
(D) originating from peripheral parts of normal-term placentas (E,F) and central parts of 
placentas delivered between 26th and 32nd week of pregnancy (A,C) and 33rd and 37th 
week of pregnance (B,D). 
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Fig. 3. Optical density of estrogen receptor ER- in some cells originating from peripheral 
part of human placentas originating from various periods of delivery. The data represent 
mean values ± SD. * - statistically significant (p<0.05) in comparison with normal group 
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group I and in the control group it was even lower (Figure 1). All the detected differences 
between reaction product content following the reaction detecting estrogen receptor ER- in 
endothelial cells of studied groups proved significant. 
A similar tendency was disclosed in peripheral portions of placentas. Also in this case the 
highest optical density in endothelial cells with expression of estrogen receptor ER- was 
detected in placentas from the pre-term deliveries between 26th and 32nd week of 
pregnancy. In the experimental group II, the content of reaction product following the 
reaction detecting estrogen receptor ER- clearly decreased (Figure 3) and resembled the 
values noted in placentas from at term deliveries. 
In the analyzed time periods of pregnancy no significant differences were disclosed in the 
content of reaction product following reaction for estrogen receptor ER- between the centre 
and the periphery of placenta. 
In fibroblasts of central placenta portions, originating from group I of pre-term deliveries 
optical density of cells with expression of estrogen receptor ER- reached the lowest value 
(Figures 1 and 2). In the subsequent group a rising tendency was noted and in the placentas 
at term the detected level corresponded to 150% of the values observed in group I. 
In peripheral portions of placentas originating from pre-term deliveries between 26th and 
32nd week of pregnancy optical density of fibroblasts with expression of estrogen receptor 
ER- was comparable to values obtained in the remaining two groups.  
No significant differences were disclosed in the product content following the reaction for 
estrogen receptor ER-between fibroblasts situated in the centre as compared to those at the 
periphery of placentas. 
In central portions of placentas originating from pre-term deliveries between 26th and 32nd 
week of pregnancy optical density of Hofbauer’s cells with expression of estrogen receptor 
ER- reached the highest value. In the subsequent analyzed experimental groups a rapid 
decrease was noted in the content of reaction product following the test for estrogen 
receptor ER-, and in the group of placentas originating from deliveries between 33rd and 
37th week of pregnancy the level amounted to 60% of the group I level and in placentas 
from at term deliveries it was even lower (Figure 1). 
In cases of peripheral placenta portions the content of reaction product in Hofbauer’s cells 
following the test for estrogen receptor ER- was comparable in all the three investigated 
groups of placentas (Figure 3). 
Upon comparison of the reaction product content in Hofbauer’s cells following the test for 
estrogen receptor ER- between central and peripheral portions of the placentas significant 
inter-zone differences were disclosed in placentas originating from at term deliveries and 
pre-term deliveries of group II. 
3.2 Estrogen receptor ER- 
Following evaluation of ER- levels in decidua cells the central portions of placentas 
originating from deliveries from 26th – 32nd week and 33rd – 37th week contained a similar 
optical density of the reaction product and an evidently higher optical density than that 
noted in placenta following at term deliveries (Figures 4 and 5). The same analysis  
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Fig. 4. Optical density of estrogen receptor ER- in some cells originating from central part 
of human placentas originating from various periods of delivery. The data represent mean 
values ± SD. * - statistically significant (p<0.05) in comparison with normal group 
 
 
Fig. 5. Expression of estrogen receptor ER- in decidual cells indicated by arrow (A,B), 
syncytiotrophoblasts (arrow) (C,D,E), endothelial cells (asterix) (C,D), and Hofbauer’s cells 
(asterix) (E) and amnion epithelium (arrow) (F) originating from peripheral parts of normal-
term placentas (B,D), central parts of placentas delivered between 26th and 32nd week of 
pregnancy (A,C) and 33rd and 37th week of pregnance (E,F). 
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performed in peripheral portions of the placentas detected in all cases the same levels of ER-
 expression (Figure 6).  
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Fig. 6. Optical density of estrogen receptor ER- in some cells originating from peripheral 
part of human placentas originating from various periods of delivery. The data represent 
mean values ± SD. * - statistically significant (p<0.05) in comparison with normal group 
Upon comparison of the reaction product content following the test for estrogen receptor 
ER- in decidua cells originating from either central or peripheral placenta portions 
significant differences were detected exclusively in the placenta originating from at term 
deliveries. 
Analysis of ER- distribution in endothelial cells of the central portion of placenta 
manifested a slight tendency for rising concentration of the receptor beginning at placentas 
from deliveries in 26th-32nd week and ending at placentas following at term deliveries 
(Figures 4 and 5). Comparable changes in concentrations of the receptor were noted in 
peripheral portions of placentas (Figure 6).  
In the analyzed time periods of pregnancies no significant differences were observed 
between the centre and periphery of placentas in the content of reaction product in 
endothelial cells following the test for estrogen receptor ER- 
The levels of ER- receptor in fibroblasts were comparable in all studied groups, both in the 
central and the peripheral portions (Figures 4 and 6).  
Analysis of the content of reaction product in fibroblasts following the test for estrogen 
receptor ER-disclosed no significant differences between placental central and peripheral 
portions. 
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In contrast, levels of ER- in Hofbauer’s cells in the experimental groups proved to be 
significantly lower than in the control, both in the central and in the peripheral portions 
(Figures 4 and 6).  
Upon comparison of reaction product content in Hofbauer’s cells following the test for 
estrogen receptor ER- in the central vs the peripheral portions of placenta no significant 
inter-zone differences were noted in the studied groups of placentas. 
In central portions of placentas originating from deliveries between 26th and 32nd week of 
pregnancy amnion epithelial cells with expression of estrogen receptor ER- demonstrated 
the highest optical density. In the subsequent experimental group a decrease was noted in 
the content in the product of a reaction for estrogen receptor ER- to the level comparable 
to that noted in placentas following at term deliveries. 
Cells of amnion epithelium in peripheral portions of placentas originating from deliveries 
between 26th to 32nd week of pregnancy demonstrated optical density observed in the 
remaining two investigated groups of placentas. 
Analysis of optical density in amnion epithelial cells with expression of estrogen receptor 
ER- demonstrated no significant differences between centre and periphery of placenta. 
In central portions of placentas optical density of the reaction product in 
syncytiotrophoblast cells following the test for estrogen receptor ER- was analogous in all 
the investigated groups (Figure 4). 
In peripheral portions of placentas optical density in syncytiotrophoblast cells with 
expression of estrogen receptor ER- demonstrated a similar level in the experimental 
groups and a clearly lower level in the control group (Figure 6). 
Comparison of optical densities in syncytiotrophoblast cells with expression of estrogen 
receptor ER- disclosed no significant differences between experimental groups but they 
differed significantly in this respect from the control group. 
4. Discussion 
The presence of estrogens receptors in human tissues used to be evaluated by several 
investigators using various techniques, including RT-PCR, in situ hybridization and 
immunohistochemistry. The studies demonstrated their presence both in estrogen-
dependent tissues and in tissues not recognized as estrogen-dependent, situated beyond the 
genital organs. Detailed recognition of estrogen receptor significance in organs and tissues 
functionally distant from generative functions is important for diagnosis and therapy of 
several diseases in men and women. 
Expression of ER- and ER- has been examined in normal placentas and pre-term delivered 
placentas of women with diabetes mellitus and arterial hypertension. Pre-term placentas have 
demonstrated a clearly higher than normal level of ER- in line with the report of Schiessl et 
al. [26]. However, our observation pertained the central portion of placenta. Akram et al. [27] 
suggest the possible roles of ER and PR expression in the pathogenesis of both fetal growth 
restriction and preeclampsia, with lower levels contributing to higher likelihoods of disease 
outcome. ER- is known to play a significant role in proliferation processes. High levels of the 
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receptor may point to elevated requirements of estrogens. This may be linked to reconstruction 
of this portion of placenta. It should be kept in mind that in the third trimester of pregnancy 
and following the 32nd week of pregnancy in particular placenta may develop various 
abnormalities, frequently defined as senescence of placenta [28,29]. In general, the 
abnormalities are linked to degeneration of villi although they involve also interstitial fibrosis 
and swelling of sinusoids in the villi [30,31]. The more pronounced proliferation in this portion 
of placenta (unpublished data) may point to such alterations. However, we should remember 
that involvement of ER- receptor is indispensable in terminal maturation of estrogen-
dependent cells. In our studies expression of the receptor in placentas of experimental groups 
has been evidently higher than in normal placentas. Earlier a similar observation was 
published by Bukovsky et al. [32,33], who in addition documented the unique role of ER- in 
the control of placental function. Since trophoblast represents the principal source of placental 
hormones, high expression of ER- and ER- in trophoblast cells may be linked to estrogen 
stimulation of placental hormone production. 
The wide range of ER- manifestation and its presence in organs which lack ER- and in 
organs which till now have been thought to be untypical for effects of estrogens, such as 
lungs, intestines, urinary bladder, proves that ER- does not just reproduce the classical 
receptor but that it carries its specific functions. A detailed recognition of significance of 
estrogen receptors in organs and tissues functionally distant from progenitor functions is 
important for diagnosis and therapy of multiple diseases both in women and men.  
The observed augmented immunoreactivity of ER-in our studies, e.g., decidual cells or in 
amnion epithelium should not be surprising. Taylor and Al-Azzawi [6] observed different 
distribution and expression of the receptor in resting and proliferating mammary gland. The 
same team demonstrated that in uterus ER- was detected in cell nuclei of all stromal cells. 
This proves that ER- may be of high significance in development of some organs.  
According to our knowledge individual reports only pertained localization of estrogen 
receptors in human placenta and no data are available as to the cellular distribution of the 
receptors in vicinity of umbilical cord and, independently, at the periphery of placenta.  
Both in central and peripheral placenta portions on its fetal side a nuclear and cytoplasmic 
localization of the receptors has been observed in variable intensities in various cells. Estrogen 
receptor ER- has been noted in fibroblasts of amnion, in cell nuclei of cytotrophoblast cells of 
the chorionic plate. The cytoplasmic reaction has been detected in some stromal cells of 
chorionic trunks while nuclear and cytoplasmic reaction has been noted in endothelial cells of 
some large vessels. Within the villi a nuclear reaction has been documented in cytotrophoblast 
cells, nuclear and cytoplasmic reaction in vascular endothelium cells and a cytoplasmic 
reaction has been noted in Hofbauer’s cells. Both nuclear and cytoplasmic reaction has been 
detected in decidua cells and fibroblasts while the nuclear reaction has characterized 
cytotrophoblast cells in basal membrane of the placenta. The observation has confirmed the 
earlier reports on the matter [6]. The data confirm that in certain tissues cells exhibit an 
exclusive expression of the nuclear receptor only while in other cells both the nuclear and the 
cytoplasmic forms of the receptor are produced.  
In the analysed time periods of pregnancy no changes in localization of estrogen receptor 
ER-have been disclosed in either central or peripheral portions of placenta but differences 
have been detected in the content of reaction product following the test for estrogen receptor 
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ER- (Figures 1 and 3). Differences have also been noted in optical density of cells 
manifesting expression of estrogen receptor ER-between centre and periphery of placentas 
in the analyzed groups. 
On the fetal side, both in the central and peripheral portions of placenta, a nuclear reaction 
for estrogen receptor ER-has been observed in epithelial cells of the amnion while both 
nuclear and cytoplasmic reaction has characterized fibroblasts of the amnion. In 
syncytiotrophoblast cells of chorionic plate a cytoplasmic reaction has been detected. In 
chorionic trunks and in villi nuclear reaction has been documented in endothelial cells and a 
cytoplasmic reaction in syncytiotrophoblast cells.  
Within villi a cytoplasmic reaction has been seen also in Hofbauer’s cells. Both nuclear and 
cytoplasmic reaction has been detected in decidua cells and in fibroblasts and a cytoplasmic 
reaction in syncytiotrophoblast cells in basal membrane of the placenta. 
In analogy to the estrogen receptor ER-localization of estrogen receptor ER-has shown 
no alterations in the studied periods on pregnancy. Even if in most tissues distribution of 
ER- seems to be linked to expression of ER- expression of ER- does not seem to be 
related to expression of ER-. On the other hand, differences in optical density have been 
detected between cells with expression of estrogen receptor ER- located in placenta centre 
as compared to placenta periphery and between groups of various duration of pregnancy 
(Figures 4 and 6). Moreover, differences have been documented in intensity of the reaction 
product following the test for estrogen receptor ER-between central and peripheral 
portions of placentas in the analyzed groups. 
Similarly to suggestions of Bukovsky et al. [32], our studies manifest that ER- is sufficient for 
basic differentiation of estrogen-sensitive tissues. Lack of ER- results in defects in 
morphology of terminally differentiated tissues and our results show that expression of ER- 
is required for final differentiation of estrogen-dependent tissues. This applies to 
cytotrophoblast cells, decidua cells and Hofbauer’s cells. If the placentas originating from pre-
term deliveries contained degenerative lesions, the high level of ER- expression in the above 
mentioned cells may indicate that highly advanced reparative processes develop in the 
placentas. Su et al. [33] hypothesize that endothelial ER-appears to be a master regulator of 
prostanoid biosynthesis and contributes to high-resistance fetoplacental blood flow. 
We were studied expression of estrogen receptors in term and pre-term delivered (induced 
by hypertension) placentas. Higher expression ER- was observed in central zone of pre-
term placentas than in term placentas. In peripheral there were no significant differences in 
ER- content. ER- expression was in pre-term placentas higher only in decidual cells and 
syncytiotrophoblast.  
Its known that estrogen receptors play role in proliferation cells angiogenesis. Differences in 
ER contents in placentas from normal and pathological pregnancies may indicate on 
changes in estrogen synthesis or theirs placental transport, what may be reason of 
hypertension development. 
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